Bellerophon Therapeutics, Inc.·4

Jan 4, 4:30 PM ET

Shah Parag Suresh 4

4 · Bellerophon Therapeutics, Inc. · Filed Jan 4, 2019

Insider Transaction Report

Form 4
Period: 2019-01-02
Shah Parag Suresh
VP Proj Mgmt & Distribution
Transactions
  • Award

    Stock Option (right to buy)

    2019-01-02+12,500260,000 total
    Exercise: $0.88Exp: 2029-01-02Common Stock (12,500 underlying)
Footnotes (1)
  • [F1]1. This option was granted on January 2, 2019. This option vests in quarterly installments over a four-years period from the date of grant.

Documents

1 file
  • 4
    wf-form4_154663742584514.xmlPrimary

    FORM 4